The Injectables: What, When, and Which One? Updates on Intravitreal Anti-VEGF drugs and steroids

The Injectables: What, When, and Which One? Updates on Intravitreal Anti-VEGF drugs and steroids

‎

Saved in:

Bibliographic Details
Main Authors:	Kristine Corpus, MD, Marie Joan Loy, MD
Format:	Article
Language:	English
Published:	Philippine Academy of Ophthalmology 2015-06-01
Series:	Philippine Journal of Ophthalmology
Online Access:	https://paojournal.com/index.php/pjo/article/view/183
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Consensus on the Intravitreal Injection Technique among Infants with Retinopathy of Prematurity by the Vitreo-Retina Society of the Philippines
by: Marie Joan V. Loy, MD, et al.
Published: (2020-12-01)

Consensus on the Intravitreal Injection Technique by the Vitreo-Retina Society of the Philippines
by: Jose Luis de Grano, MD, et al.
Published: (2014-06-01)

Intravitreal Injection of Anti-VEGF Antibody Induces Glomerular Endothelial Cells Injury
by: F. Touzani, et al.
Published: (2019-01-01)

Erratum: Bedside bilateral sequential intravitreal anti-VEGF injections for retinopathy of prematurity
Published: (2025-01-01)

Efficacy and safety of prophylactic simultaneous intravitreal moxifloxacin injection with standard intravitreal anti-VEGF injection procedure in cases of cystoid macular edema and macular neovascularization
by: Mohamed Nagy Elmohamady, et al.
Published: (2025-05-01)

One-year results of visual response following intravitreal novel anti-VEGF injection for diabetic macular edema in a Latino population
by: Guillermo Salcedo-Villanueva, et al.
Published: (2025-08-01)

Contributing factors to short-term intraocular pressure elevation following intravitreal anti-VEGF injections
by: Yanchen Liu, et al.
Published: (2025-05-01)

Management and safety of same day bilateral intravitreal anti-VEGF injections in a treat-and-extend regimen
by: Christina Plasencia, et al.
Published: (2025-08-01)

Multiple serous retinal detachments after Anti-VEGF Intravitreal Injection for pachychoroid related choroidal neovascularization
by: Huilin Liang, et al.
Published: (2024-12-01)

Knowledge, attitudes, and practices of patients with age-related macular degeneration (AMD) towards Anti-VEGF treatment under one-stop intravitreal injection model
by: Liangzhang Tan, et al.
Published: (2024-11-01)

Intravitreal Steroids for the Treatment of Retinal Diseases
by: Valentina Sarao, et al.
Published: (2014-01-01)

Vitreous Inflammation Associated with Intravitreal Anti-VEGF Pharmacotherapy
by: Shivi Agrawal, et al.
Published: (2013-01-01)

Macular edema in Wyburn-Mason syndrome: Resolution with anti-VEGF intravitreal injections. Case report and review of the literature
by: Nathan Hupin, et al.
Published: (2024-12-01)

Retinal toxicity of moxifloxacin injected intravitreally into rabbit eyes
by: Leandro Jose G. Domalanta, MD, et al.
Published: (2005-03-01)

Efficacy and safety of intravitreal anti-VEGF for myopic choroidal neovascularization
by: Jing-Yao Liu, et al.
Published: (2025-09-01)

Timing of vitrectomy for treatment of endophthalmitis after intravitreal anti-VEGF injection: a systematic literature review of case reports and series
by: Daniel J. Hu, et al.
Published: (2025-01-01)

Treatment of juxtapapillary toxoplasmic retinochoroiditiswith intravitreal clindamycin and dexamethasone injection
by: Edmin Michael G. Santos, MD
Published: (2008-12-01)

Intravitreal injections: antibiotics or antiseptics?
by: I. E. Ioshin, et al.
Published: (2018-10-01)

Long Term Outcome and Histologic Findings of a Retinal Astrocytic Hamartoma Treated with Intravitreal Injection of Anti-VEGF: A Case Report
by: Kinza T. Ahmad, et al.
Published: (2021-01-01)

The evaluation of the effects before and after the establishment of a one-stop intravitreal injection center
by: HUANG Xuelian, et al.
Published: (2025-03-01)

Analyzing the Carbon Footprint of an Intravitreal Injection
by: Barry Power, et al.
Published: (2021-07-01)

Analysis of intravitreal using of anti vegf-medications for diseases of fundus accompanied by exudation and neovascularization
by: N. G. Zavgorodnya, et al.
Published: (2013-08-01)

Anti-VEGF Therapy and the Retina: An Update
by: Vikas Tah, et al.
Published: (2015-01-01)

Ganglion Formation After Steroid Injection for Stenosing Flexor Tenosynovitis
by: Kazuhiro Kohata, MD, PhD, et al.
Published: (2025-09-01)

Treatment Cessation in Patients with Diabetic Maculopathy under Intravitreal Anti-VEGF Therapy Following a Treat-and-Extend Protocol
by: Lucia Saucedo, PhD, et al.
Published: (2025-11-01)

When is it safe to operate after the failure of therapeutic steroid injections in carpal tunnel syndrome?
by: Umar Nadeem, et al.
Published: (2024-05-01)

On elevation of intraocular pressure after intravitreal injections
by: S. M. Bauer, et al.
Published: (2022-01-01)

Epiretinal Membrane Is Associated with Diabetic Retinopathy Severity and Cumulative Anti-VEGF Injections
by: Shinji Kakihara, MD, PhD, et al.
Published: (2025-05-01)

Systemic Effects of Intravitreal Anti-VEGF Therapy: A Review of Safety across Organ Systems
by: Mousumi Banerjee, et al.
Published: (2025-06-01)

Macular Hole Progression following Ocriplasmin Intravitreal Injection
by: Edward Casswell, et al.
Published: (2014-01-01)

Comparison of Two Anesthetic Methods for Intravitreal Ozurdex Injection
by: V. Levent Karabaş, et al.
Published: (2015-01-01)

Safety of Intravitreal Injection of Biosimilar of Aflibercept in Rabbit Eyes
by: Alireza Lashay, et al.
Published: (2020-01-01)

Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection
by: Elcin Suren, et al.
Published: (2020-01-01)

Acute Acanthamoeba panophthalmitis following intravitreal drug injection
by: Worawut Worawutwittaya, et al.
Published: (2025-01-01)

WHO recommendations on uterotonics for postpartum haemorrhage prevention: what works, and which one?
by: Joshua P Vogel, et al.
Published: (2019-03-01)

The Short-Term Effect of Intravitreal Bevacizumab Injection on Intraocular Pressure
by: Şehnaz Özçalışkan, et al.
Published: (2014-10-01)

Corneal Endothelial Cell Changes Associated with Multiple Intravitreal Injections
by: Mariaelena Malvasi, et al.
Published: (2024-07-01)

Safety Evaluation of Bilateral Same-Day Intravitreal Injection of Faricimab
by: Michael D. Karampelas, et al.
Published: (2025-06-01)

Discordance Among Patients and Ophthalmologists Regarding the Burden of Intravitreal Injections
by: Robinson K, et al.
Published: (2025-08-01)

Delayed-onset Moraxella nonliquefaciens endophthalmitis following intravitreal injection
by: Paul S. Micevych, et al.
Published: (2025-09-01)